Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
Feb 4 (Reuters) - Medical device maker Abbott Laboratories has reported 860 serious injuries linked to the recall of some of ...
Abbott Laboratories (ABT) stock is down as the FDA classifies the company's recent recall of FreeStyle Libre 3 glucose ...
In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...
FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.
Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...
Socrates Health Solutions ("Socrates"), advancing a purpose-led mission to pursue a better feedback loop for health issues spanning diabetes management, broader health optimization and athletic ...
Feb 4 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified Abbott's recall of certain glucose monitoring ...
The Food and Drug Administration (FDA) has now identified the recall of certain FreeStyle Libre glucose monitor sensors as ...
Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results